Physicians and drug representatives: Exploring the dynamics of the relationship

Journal of General Internal Medicine

Volumn 22, Issue 2, 2007, Pages 184-190

  Chimonas, Susan ^a   Brennan, Troyen A ^b   Rothman, David J ^a  

^a Howard Hughes Medical Institute   (United States)

^b AETNA   (United States)

Author keywords

Health policy; Physician behavior; Professionalism; Qualitative research; Social science

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; DRUG INDUSTRY; DRUG INFORMATION; DRUG MARKETING; FEMALE; HEALTH CARE POLICY; HUMAN; INFORMATION DISSEMINATION; MALE; PATIENT CARE; PHYSICIAN; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PROFESSIONALISM; QUALITATIVE ANALYSIS; ETHICS; GENERAL PRACTITIONER; MARKETING; MEDICINE; METHODOLOGY; PUBLIC RELATIONS;

CONFLICT OF INTEREST; DRUG INDUSTRY; HUMANS; INTERPROFESSIONAL RELATIONS; MARKETING; PHYSICIANS; PHYSICIANS, FAMILY; SPECIALTIES, MEDICAL;

EID: 34250327521     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-006-0041-z     Document Type: Article

References (36)

1. Rodwin MA. Medicine, Money, and Morals: Physicians' Conflict of Interest. Oxford: Oxford University Press; 1993.
2. Murray T. Conflict of interest in the professions. N Engl J Med. 2002; 346:1835-6.
3. Dana J, Lowenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290(2):252-5.
4. Consumers Union. Requiring Drug Companies to Disclose Marketing Expenditures to Physicians. Available at http://www.consumersunion.org/ campaigns/learn_more/001813indiv.html. Accessed April 21, 2006.
5. Wazana A. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA. 2000;283:373-80.
6. Lexchin J. Interactions between physicians and the pharmaceutical industry: What does the literature say? Can Med Assoc J. 1993; 149:1401-7.
7. Pear R. Drug industry is told to stop gifts to doctors. The New York Times. October 1, 2002;A1.
8. Chimonas S, Rothman DJ. New federal guidelines for physician- pharmaceutical industry relations: the politics of policy formation. Health Aff. 2005;24,4:949-60.
9. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physician relationships with the pharmaceutical industry: Self-regulation in the shadow of federal prosecution. N Engl J Med. 2004; 351:1891-1900.
10. Anderson T. "Drug launches and the impact of pharmaceutical promotion on physician treatment decisions." Report presented at Prudential Financial/ImpactRx Joint Industry Conference, Omni Berkshire Place, New York, NY, June 20, 2003. Available at http://www.impactrx.com/pdfs/ Prudential_Financial_ImpactRx_Joint_Industry_Conference.pdf. Accessed August 23, 2005.
11. Medical Professionalism Project. Medical professionalism in the new millennium: a physician charter. Ann Intern Med. 2002;136:243-46.
12. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003; 163:2213-18.
13. Reeder M, Dougherty J, White L. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993; 22:1593-6.
14. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns, and clerks. Can Med Assoc J. 1995;153:553-9.
15. Sergeant M, Hodgetts P, Godwin M, Walker D, McHenry P. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario. Can Med Assoc J. 1996;155:1243-8.
16. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich, EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-7.
17. Banks J, Mainous A. Attitudes of medical school faculty toward gifts from the pharmaceutical industry. Acad Med. 1992;67:610-12.
18. Keim S, Sanders A, Witzke D, Dyne P, Fulginiti J. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med. 1993;22:1576-81.
19. Steinman M, Shlipak M, McPhee S. Of principles and pens: attitudes and practices of medicine house staff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-7.
20. Madhavan S, Amonkar M, Elliott D, Burke K, Gore P. The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. J Clin Pharm Ther. 1997;22:207-15.
21. Festinger L, Riecken H, Schachter S. When Prophecy Fails. Minneapolis, MN: Lund Press; 1956.
22. Festinger L. A Theory of Cognitive Dissonance. Stanford, CA: Stanford University Press; 1957.
23. Morgan D. Focus Groups as Qualitative Research. 2nd edition. Thousand Oaks, CA: Sage Publications; 1997.
24. American Medical Association. "Gifts to physicians from industry." JAMA 1991;265:501.
25. Pharmaceutical Research and Manufacturers of America. "PhRMA code on interactions with healthcare professionals." Available at http://www.phrma.org/files/PhRMA%20code.pdf. Accessed December 8, 2006.
26. Office of the Inspector General. Compliance program guidance for pharmaceutical manufacturers. Fed Regist. 2003;68,86:23731-43.
27. Carroll R. "Cognitive dissonance." The Skeptic's Dictionary: A Collection of Strange Beliefs, Amusing Deceptions, and Dangerous Delusions. Hoboken, NJ: John Wiley & Sons; 2003.
28. Coyle S. Physician-industry relations. Part 1: individual physicians. Ann Intern Med. 2002;136:396-402.
29. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295,4:429-33.
30. Hensley S. "As Drug Bill Soars, Some Doctors Get an 'Unsales' Pitch." The Wall Street Journal. March 13, 2006;A1.
31. Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents' perceptions over time of pharmaceutical industry: interactions and gifts and the effect of an educational intervention. Acad Med. 2006;81(7):595-602.
32. Appleby J. "Sales pitch: Drug firms use perks to push pills." USA Today. May 16, 2001;B1.
33. California Senate Bill 1765, Chapter 927, September 2004. Available at http://www.venable.com/docs/pubs/1204.pdf. Accessed December 8, 2006.
34. Allen D. "Drug companies woo Vermont doctors." The Barre Montpelier Times (Argus and Rutland Herald). May 29, 2005: A1, A6.
35. Vermont Pharmaceutical Manufacturer Gift Disclosure Law (33 V.S.A. § 2005). Available at http://www.atg.state.vt.us/display.php?smod=177. Accessed August 23, 2005.
36. Arnold & Porter, LLP. "Pharmaceutical Companies Face New State Marketing Disclosure Laws. Arnold & Porter Update." Available at http://www.arnoldporter.com/pubs/files/Pharma_Marketing_Disclosure_Laws.PDF. Accessed March 17, 2006.